Paul Edison, MD, PhD, of Imperial College London, who wasn't involved with the studies, called the findings "an undeniable ...

An older oral version of the company's semaglutide drug failed to meet its main goal in late-stage trials testing whether the ...

Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

"While semaglutide did not demonstrate efficacy in slowing the progression of Alzheimer's disease, the extensive body of ...

The studies were a setback for the optimistic view that semaglutide and other drugs used in obesity and diabetes treatment could help prevent a number of brain diseases.

A new study finds a possible association between GLP-1 drugs like semaglutide and chronic cough, though the authors are ...

WBO and IBF champion Janibek Alimkhanuly tests positive for a banned substance before his scheduled middleweight unification ...